Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | MGLL | Q99685 | 3/20 | 0.34 |
| ▸ | PGR | P06401 | 2/20 | 0.34 |
| ▸ | FAAH | O00519 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.34 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.33 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6426808 | 0.98 | HSD11B1 (0.37) | HSD11B1HPGDSLC6A3TSHRMGLL | |
| SCHEMBL6423781 | 0.94 | PDE2A (0.35) | SLC6A3MGLLFAAHCYP3A4CYP2D6 | |
| SCHEMBL6425963 | 0.93 | PDE2A (0.35) | MGLLFAAHKCNH2 | |
| SCHEMBL6425613 | 0.91 | AKR1C3 (0.41) | MGLLCYP3A4CYP2D6CYP2C9KCNH2 | |
| SCHEMBL6424919 | 0.90 | MEN1 (0.37) | HSD11B1MGLLPGRFAAHCYP3A4 | |
| SCHEMBL6423179 | 0.89 | AKR1C3 (0.41) | SLC6A3MGLLCYP2D6CYP1A2CYP2C9 | |
| SCHEMBL6426909 | 0.89 | KMT2A (0.35) | HSD11B1MGLLFAAH | |
| SCHEMBL6423904 | 0.89 | AKR1C3 (0.37) | HSD11B1HPGDMGLL | |
| SCHEMBL6423706 | 0.88 | L3MBTL1 (0.39) | HSD11B1SLC6A3MGLLSLC6A4 | |
| SCHEMBL6426037 | 0.88 | MEN1 (0.37) | HSD11B1MGLLPGRFAAHCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050234244-A1 | Synthesis of COX-2 and FAAH inhibitors | IRONWOOD PHARMACEUTICALS, INC. | 2005-10-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050234244-A1 | Synthesis of COX-2 and FAAH inhibitors | FAAH2, FAAH, PTGES2 | HSD11B1 1120/4885HPGD 15/4885SLC6A3 3446/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.